AIMS: Primary intraosseous rhabdomyosarcoma (RMS) is a rare entity defined by EWSR1/FUS-TFCP2 or, less commonly, MEIS1-NCOA2 fusions. The lesions often show a hybrid spindle and epithelioid phenotype, frequently coexpress myogenic markers, ALK, and cytokeratin, and show a striking propensity for the pelvic and craniofacial bones. The aim of this study was to investigate the clinicopathological and molecular features of 11 head and neck RMSs (HNRMSs) characterised by the genetic alterations described in intraosseous RMS. METHODS AND RESULTS: The molecular abnormalities were analysed with fluorescence in-situ hybridisation and/or targeted RNA/DNA sequencing. Seven cases had FUS-TFCP2 fusions, four had EWSR1-TFCP2 fusions, and none had MEIS1-NCOA2 fusions. All except one case were intraosseous, affecting the mandible (n = 4), maxilla (n = 3), and skull (n = 3). One case occurred in the superficial soft tissue of the neck. The median age was 29 years (range, 16-74 years), with an equal sex distribution. All tumours showed mixed epithelioid and spindle morphology. Immunohistochemical coexpression of desmin, myogenin, MyoD1, ALK, and cytokeratin was seen in most cases. An intragenic ALK deletion was seen in 43% of cases. Regional and distant spread were seen in three and four patients, respectively. Two patients died of their disease. CONCLUSIONS: We herein present the largest series of HNRMSs with TFCP2 fusions to date. The findings show a strong predilection for the skeleton in young adults, although we also report an extraosseous case. The tumours are characterised by a distinctive spindle and epithelioid phenotype and a peculiar immunoprofile, with coexpression of myogenic markers, epithelial markers, and ALK. They are associated with a poor prognosis, including regional or distant spread and disease-related death.
AIMS: Primary intraosseous rhabdomyosarcoma (RMS) is a rare entity defined by EWSR1/FUS-TFCP2 or, less commonly, MEIS1-NCOA2 fusions. The lesions often show a hybrid spindle and epithelioid phenotype, frequently coexpress myogenic markers, ALK, and cytokeratin, and show a striking propensity for the pelvic and craniofacial bones. The aim of this study was to investigate the clinicopathological and molecular features of 11 head and neck RMSs (HNRMSs) characterised by the genetic alterations described in intraosseous RMS. METHODS AND RESULTS: The molecular abnormalities were analysed with fluorescence in-situ hybridisation and/or targeted RNA/DNA sequencing. Seven cases had FUS-TFCP2 fusions, four had EWSR1-TFCP2 fusions, and none had MEIS1-NCOA2 fusions. All except one case were intraosseous, affecting the mandible (n = 4), maxilla (n = 3), and skull (n = 3). One case occurred in the superficial soft tissue of the neck. The median age was 29 years (range, 16-74 years), with an equal sex distribution. All tumours showed mixed epithelioid and spindle morphology. Immunohistochemical coexpression of desmin, myogenin, MyoD1, ALK, and cytokeratin was seen in most cases. An intragenic ALK deletion was seen in 43% of cases. Regional and distant spread were seen in three and four patients, respectively. Two patients died of their disease. CONCLUSIONS: We herein present the largest series of HNRMSs with TFCP2 fusions to date. The findings show a strong predilection for the skeleton in young adults, although we also report an extraosseous case. The tumours are characterised by a distinctive spindle and epithelioid phenotype and a peculiar immunoprofile, with coexpression of myogenic markers, epithelial markers, and ALK. They are associated with a poor prognosis, including regional or distant spread and disease-related death.
Authors: Narasimhan P Agaram; Lei Zhang; Yun-Shao Sung; Marcela S Cavalcanti; Dianne Torrence; Leonard Wexler; Glenn Francis; Scott Sommerville; David Swanson; Brendan C Dickson; Albert J H Suurmeijer; Richard Williamson; Cristina R Antonescu Journal: Am J Surg Pathol Date: 2019-05 Impact factor: 6.394
Authors: Grzegorz Kotarba; Ewa Krzywinska; Anna I Grabowska; Agnieszka Taracha; Tomasz Wilanowski Journal: Cancer Lett Date: 2018-02-07 Impact factor: 8.679
Authors: Rita Alaggio; Lei Zhang; Yun-Shao Sung; Shih-Chiang Huang; Chun-Liang Chen; Gianni Bisogno; Angelica Zin; Narasimhan P Agaram; Michael P LaQuaglia; Leonard H Wexler; Cristina R Antonescu Journal: Am J Surg Pathol Date: 2016-02 Impact factor: 6.394
Authors: Narasimhan P Agaram; Michael P LaQuaglia; Rita Alaggio; Lei Zhang; Yumi Fujisawa; Marc Ladanyi; Leonard H Wexler; Cristina R Antonescu Journal: Mod Pathol Date: 2018-09-04 Impact factor: 7.842
Authors: Bin Xu; Koping Chang; Andrew L Folpe; Yu-Chien Kao; Shiuan-Li Wey; Hsuan-Ying Huang; Anthony J Gill; Lisa Rooper; Justin A Bishop; Brendan C Dickson; Jen-Chieh Lee; Cristina R Antonescu Journal: Am J Surg Pathol Date: 2020-06 Impact factor: 6.298
Authors: Jennifer L S Willoughby; Kelly George; Mark P Roberto; Hang Gyeong Chin; Patrick Stoiber; Hyunjin Shin; Chandra Sekhar Pedamallu; Scott E Schaus; Kevin Fitzgerald; Jagesh Shah; Ulla Hansen Journal: BMC Cancer Date: 2020-06-15 Impact factor: 4.430
Authors: Guo Zhu; Ryma Benayed; Caleb Ho; Kerry Mullaney; Purvil Sukhadia; Kelly Rios; Ryan Berry; Brian P Rubin; Khedoudja Nafa; Lu Wang; David S Klimstra; Marc Ladanyi; Meera R Hameed Journal: Mod Pathol Date: 2018-11-21 Impact factor: 7.842
Authors: Carlos N Prieto-Granada; Bin Xu; Bayan Alzumaili; Mohamed Rizwan Haroon Al Rasheed; Antoine Eskander; Danny Enepekides; Snehal G Patel; Todd M Stevens; Snjezana Dogan; Ronald Ghossein; Nora Katabi Journal: Virchows Arch Date: 2021-05-12 Impact factor: 4.535